Answers are grounded in this paper and cite their sources.
Background: Intravascular lithotripsy (IVL) delivers acoustic pressure waves to modify calcification to enhance vessel compliance and optimize stent deployment. The Disrupt CAD IV study enrolled patients with severe coronary artery calcification. The primary safety (30-day major adverse coronary events [MACE], 6.3%) and effectiveness (procedural success, 93.8%) endpoints were achieved. The present analysis evaluated the 2-year outcomes of the study.
No takes yet. Share an insight, caveat, or question.
Saito et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: